![Randall K. Johnson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Randall K. Johnson
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
133
| Public Company | Pharmaceuticals: Major | 133 |
Callisto Pharmaceuticals, Inc.
![]() Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.
12
| Extinct | Pharmaceuticals: Major | 12 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Randall K. Johnson tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Bausch Health Americas, Inc.
![]() Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer General Counsel Corporate Officer/Principal | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
OKYO PHARMA LIMITED | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director of Finance/CFO | |
INDIVIOR PLC | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
GSK Equity Investments Ltd.
![]() GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President Corporate Officer/Principal President Private Equity Investor | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
University of Bath | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
Imperial College London | College/University | Corporate Officer/Principal Doctorate Degree | |
University of Cambridge | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Arizona State University | College/University | Director/Board Member Undergraduate Degree | |
University of London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Bristol | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman General Counsel | |
National Academy of Medicine (United States)
![]() National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Corporate Officer/Principal Consultant / Advisor | |
CEO Roundtable on Cancer, Inc.
![]() CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
RespiVert Ltd.
![]() RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Medical Distributors | Founder Founder Chief Executive Officer | |
TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal President Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ViiV Healthcare Ltd.
![]() ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman Chief Executive Officer | |
The University of North Carolina at Charlotte | College/University | Graduate Degree Doctorate Degree | |
Stanford University School of Medicine | College/University | Corporate Officer/Principal Director/Board Member | |
The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
Sapience Therapeutics, Inc.
![]() Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Director/Board Member | |
ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Smithkline Beecham Pharmaceuticals (Canada) | Corporate Officer/Principal Sales & Marketing | ||
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 33 |
Regno Unito | 16 |
Svizzera | 3 |
Canada | 2 |
Settori
Health Technology | 28 |
Consumer Services | 14 |
Commercial Services | 5 |
Finance | 3 |
Retail Trade | 2 |
Posizioni
Director/Board Member | 476 |
Corporate Officer/Principal | 278 |
Independent Dir/Board Member | 142 |
Chairman | 122 |
Chief Tech/Sci/R&D Officer | 76 |
Contatti più connessi
Insiders | |
---|---|
Argeris Karabelas | 42 |
Tamar Howson | 41 |
Elaine Jones | 37 |
Richard Sykes | 37 |
Christopher Viehbacher | 37 |
Tim Tyson | 28 |
Jean-Pierre Garnier | 28 |
Howard H. Pien | 27 |
Robert Ruffolo | 24 |
David Wheadon | 23 |
Maxine Gowen | 23 |
Dean Mitchell | 22 |
George Poste | 21 |
Michael Owen | 20 |
Ian Gilham | 20 |
- Borsa valori
- Insiders
- Randall K. Johnson
- Connessioni Società